These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17616608)

  • 1. Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes.
    Cho YR; Kim HJ; Park SY; Ko HJ; Hong EG; Higashimori T; Zhang Z; Jung DY; Ola MS; Lanoue KF; Leiter EH; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E327-36. PubMed ID: 17616608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
    Kim JK; Zisman A; Fillmore JJ; Peroni OD; Kotani K; Perret P; Zong H; Dong J; Kahn CR; Kahn BB; Shulman GI
    J Clin Invest; 2001 Jul; 108(1):153-60. PubMed ID: 11435467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological and gene expression analysis of a polygenic diabetes model, NONcNZO10/LtJ mice.
    Hirata T; Yoshitomi T; Inoue M; Iigo Y; Matsumoto K; Kubota K; Shinagawa A
    Gene; 2017 Sep; 629():52-58. PubMed ID: 28760554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
    Mitchell PL; Nachbar R; Lachance D; St-Pierre P; Trottier J; Barbier O; Marette A
    Diabetes Obes Metab; 2017 Mar; 19(3):313-319. PubMed ID: 27800648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-insulin receptor autoantibodies are not required for type 2 diabetes pathogenesis in NZL/Lt mice, a New Zealand obese (NZO)-derived mouse strain.
    McInerney MF; Najjar SM; Brickley D; Lutzke M; Abou-Rjaily GA; Reifsnyder P; Haskell BD; Flurkey K; Zhang YJ; Pietropaolo SL; Pietropaolo M; Byers JP; Leiter EH
    Exp Diabesity Res; 2004; 5(3):177-85. PubMed ID: 15512785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice.
    Kim JH; Stewart TP; Soltani-Bejnood M; Wang L; Fortuna JM; Mostafa OA; Moustaid-Moussa N; Shoieb AM; McEntee MF; Wang Y; Bechtel L; Naggert JK
    J Endocrinol; 2006 Nov; 191(2):437-46. PubMed ID: 17088413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of insulin resistance in New Zealand obese mice.
    Veroni MC; Proietto J; Larkins RG
    Diabetes; 1991 Nov; 40(11):1480-7. PubMed ID: 1936607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes.
    Leiter EH; Reifsnyder PC; Zhang W; Pan HJ; Xiao Q; Mistry J
    Endocrinology; 2006 Feb; 147(2):919-26. PubMed ID: 16254032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.
    Buchanan J; Mazumder PK; Hu P; Chakrabarti G; Roberts MW; Yun UJ; Cooksey RC; Litwin SE; Abel ED
    Endocrinology; 2005 Dec; 146(12):5341-9. PubMed ID: 16141388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
    Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
    Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.
    Rossetti L; Stenbit AE; Chen W; Hu M; Barzilai N; Katz EB; Charron MJ
    J Clin Invest; 1997 Oct; 100(7):1831-9. PubMed ID: 9312184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.
    Park SY; Kim HJ; Wang S; Higashimori T; Dong J; Kim YJ; Cline G; Li H; Prentki M; Shulman GI; Mitchell GA; Kim JK
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E30-9. PubMed ID: 15701680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of diabetes and obesity, including the PBB/Ld mouse.
    Hunt CE; Lindsey JR; Walkley SU
    Fed Proc; 1976 Apr; 35(5):1206-17. PubMed ID: 770197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
    Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
    J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
    Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin ameliorates nephropathy despite elevating hyperglycemia in a polygenic mouse model of type 2 diabetes, NONcNZO10/LtJ.
    Reifsnyder PC; Doty R; Harrison DE
    PLoS One; 2014; 9(12):e114324. PubMed ID: 25473963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation effects of TZQ-F on adipocyte differentiation and insulin action.
    Nan Xia J; Qin Zhang D; Du J; Wen J
    J Ethnopharmacol; 2013 Nov; 150(2):692-9. PubMed ID: 24095827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.